Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TGF beta--a role in systemic sclerosis?

S A Cotton1, A L Herrick, M I Jayson

  • 1Department of Rheumatology, University of Manchester, UK.

The Journal of Pathology
|May 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis.

Scientific reports·2022
Same author

Associations with digital pitting in patients with systemic sclerosis: results of a retrospective analysis.

Scandinavian journal of rheumatology·2021
Same author

Temperature response to cold challenge and mobile phone thermography as outcome measures for systemic sclerosis-related Raynaud's phenomenon.

Scandinavian journal of rheumatology·2021
Same author

Low body weight and involuntary weight loss are associated with Raynaud's phenomenon in both men and women.

Scandinavian journal of rheumatology·2020
Same author

Imaging digital arteries in systemic sclerosis by tomographic 3-dimensional ultrasound.

Rheumatology international·2020
Same author

Upper gastrointestinal vascular ectasia: an under-recognized complication of systemic sclerosis.

Scandinavian journal of rheumatology·2020

Transforming growth factor beta (TGF-β) may play a key role in systemic sclerosis (SSc) pathogenesis. This potent factor influences fibroblast activity and collagen production, potentially driving fibrosis in SSc patients.

Area of Science:

  • Connective tissue disorders
  • Fibrosis research
  • Cellular signaling pathways

Background:

  • Systemic sclerosis (SSc) is a multisystem disorder characterized by progressive fibrosis.
  • Transforming growth factor beta (TGF-β) exhibits diverse cellular effects, including fibroblast chemoattraction and collagen synthesis.
  • Elevated collagen and fibronectin production by SSc fibroblasts, along with increased TIMP levels, suggest a role for TGF-β.

Purpose of the Study:

  • To investigate the potential role of TGF-β in the pathogenesis of systemic sclerosis (SSc).
  • To explore the mechanisms by which TGF-β may contribute to fibrosis in SSc.

Main Methods:

  • Review of existing in vitro studies on fibroblast behavior in SSc.
  • Analysis of cellular actions of TGF-β on fibroblasts and endothelial cells.

Related Experiment Videos

  • Examination of molecular markers associated with fibrosis in SSc.

    • Main Results:

    • TGF-β acts as a potent chemoattractant for human dermal fibroblasts.
    • TGF-β can induce collagen synthesis in fibroblasts, a key component of fibrosis.
    • SSc fibroblasts exhibit increased production of collagens, fibronectin, and TIMPs, consistent with TGF-β stimulation.
    • Cytotoxicity of SSc serum to endothelial cells may lead to TGF-β synthesis and secondary fibroblast stimulation.

    Conclusions:

    • TGF-β is a strong candidate mediator for fibrosis in systemic sclerosis.
    • Further research is needed to fully elucidate the precise role of TGF-β in SSc pathogenesis.
    • Understanding TGF-β's role could offer new therapeutic targets for systemic sclerosis.